Saturday, Sep 23, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Lifestyle | Study Finds Blood Cancer May Stop By Targeting Bone Cells

Study finds blood cancer may stop by targeting bone cells

New York: A new study has found that to stop acute myeloid leukaemia, one of the deadliest blood cancers, targeting neighbouring bone cells may be a better strategy. The study has been published in the ‘Cancer Discovery Journal’. Acute myeloid leukaemia (AML) is one of the hardest-to-treat blood cancers. And though it’s possible to achieve […]

By ANI
Published Date - 12:35 PM, Fri - 21 January 22
Study finds blood cancer may stop by targeting bone cells
whatsapp facebook twitter telegram

New York: A new study has found that to stop acute myeloid leukaemia, one of the deadliest blood cancers, targeting neighbouring bone cells may be a better strategy.
The study has been published in the ‘Cancer Discovery Journal’.

Acute myeloid leukaemia (AML) is one of the hardest-to-treat blood cancers. And though it’s possible to achieve remission with drugs that target and destroy the stem cells that give rise to leukaemia, the disease usually returns with deadly consequences. Patients relapse when new types of leukemic stem cells that elude all existing treatments surface.
Trying to develop additional drugs that target new stem cells is challenging, said cancer researcher Stavroula Kousteni, PhD, because cancer will eventually mutate to circumvent the drugs.

Her new study shows that targeting neighbouring cells in the bone marrow – osteoblasts, the cells which make bone – could turn a friendly environment for leukaemia cells into a hostile one.

That’s because the osteoblasts are lured into helping leukaemia stem cells, Kousteni’s team, led by Marta Galan-Diez, PhD, found. The new study revealed how leukaemia cells lure the osteoblasts to function to their advantage by releasing a molecule called kynurenine.

Kynurenine binds to a serotonin receptor (HTR1B) on the osteoblasts, sending the message to osteoblasts to help nurture leukemic cells by secreting an acute phase response protein (SAA1). SAA1 then tells the leukemia cells to make more kynurenine, and a vicious cycle ensues that leads to more disease progression.

The crosstalk between leukaemia cells and osteoblasts can be broken, Galan-Diez and Kousteni found, suggesting a way forward for new AML treatments. In experiments with mice, they found that genetically eliminating the serotonin receptor that binds to kynurenine blocks the progression of leukemic cells.

And in humanized mice carrying leukaemia cells from patients and experiencing an AML relapse, an experimental drug that inhibits kynurenine synthesis “had a substantial effect in combination with traditional chemotherapy, slowing disease progression,” Galan-Diez said. (The drug, called epacadostat, is being tested in other cancers).

In the same study, Kousteni and Galan-Diez observed increasing levels of kynurenine and SAA1 in AML patients and in patients with myelodysplastic syndrome (MDS), another haematological cancer that often transforms to AML.

Levels of both molecules increase with MDS progression to AML and SAA1 promotes proliferation of MDS and AML cells from patients, suggesting the same partnership between MDS or leukemia cells and osteoblasts is active in the human form of disease.

“The advantage of this approach is that it doesn’t matter which stem cells are causing the disease. They all need osteoblasts to grow, and if we can stop these two types of cells from communicating, we might be able to stop the disease,” Kousteni said.

In addition, the same approach may also prevent pre-leukemic conditions like MDS from progressing.

Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • Acute myeloid leukaemia
  • blood cancer
  • serotonin receptor

Related News

  • Researchers discover new approach for predicting resistance against cancer therapy

    Researchers discover new approach for predicting resistance against cancer therapy

  • Hyderabad: Blood cancer conquerors meet held at Yashoda Hospital

    Hyderabad: Blood cancer conquerors meet held at Yashoda Hospital

  • Help Save My 3-Year-Old Daughter From Cancer!

    Help Save My 3-Year-Old Daughter From Cancer!

  • My Four-Year-Old Son Needs Your Help In His Fight Against Blood Cancer

    My Four-Year-Old Son Needs Your Help In His Fight Against Blood Cancer

  • Man diagnosed with cancer ends life in Hyderabad

    Man diagnosed with cancer ends life in Hyderabad

  • Please, I need your help in saving my 2-year-old daughter from complex blood cancer

    Please, I need your help in saving my 2-year-old daughter from complex blood cancer

Latest News

  • Women’s representation in policymaking now set to increase significantly, says Anurag Thakur

    10 seconds ago
  • Former Parigi MLA Koppula Harishwar Reddy passes away

    3 mins ago
  • MP CM mocks Rahul for carrying suitcase with wheels on head, question’s Congress’ future under such a leader

    6 mins ago
  • Sector Officers, police force must work together to conduct fair elections: Returning Officer Ronald Rose

    12 mins ago
  • Dengue cases rise in Bihar

    22 mins ago
  • TN announces funeral with state honours for brain dead organ donors

    19 mins ago
  • Number of govt-recognised startups crosses 1 lakh mark

    26 mins ago
  • Ham radio enthusiasts of 3 nations meet to promote people-to-people connect across regions

    28 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam